Liabilities, Current of Regencell Bioscience Holdings Ltd from 30 Jun 2020 to 30 Jun 2025

Taxonomy & unit: us-gaap: USD
Description: Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary: Regencell Bioscience Holdings Ltd quarterly Liabilities, Current in USD history and change rate from 30 Jun 2020 to 30 Jun 2025.
Regencell Bioscience Holdings Ltd Liabilities, Current for the quarter ending 30 Jun 2025 was $663,673, a 243% increase year-over-year.
Source SEC data: View on sec.gov

Liabilities, Current, Quarterly (USD)

Liabilities, Current, YoY Quarterly Change (%)

Regencell Bioscience Holdings Ltd Quarterly Liabilities, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q2 2025	$663,673	+$470,095	+243%	30 Jun 2025	20-F	31 Oct 2025	2025	FY
Q2 2024	$193,578	-$413,336	-68%	30 Jun 2024	20-F	31 Oct 2025	2025	FY
Q2 2023	$606,914	+$29,150	+5%	30 Jun 2023	20-F	25 Oct 2024	2024	FY
Q2 2022	$577,764	-$3,760,007	-87%	30 Jun 2022	20-F	27 Oct 2023	2023	FY
Q2 2021	$4,337,771	+$1,172,861	+37%	30 Jun 2021	20-F	31 Oct 2022	2022	FY
Q2 2020	$3,164,910			30 Jun 2020	20-F	29 Oct 2021	2021	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.